MSI-H Immunotherapy Response Probability Calculator

Estimate immunotherapy response probability in MSI-H/dMMR colorectal cancer. Pembrolizumab first-line: ORR 45%, PFS2 advantage vs chemotherapy. MMR status guides checkpoint inhibitor eligibility.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How to Use

Enter the values for the scenario you are assessing. Estimate immunotherapy response probability in MSI-H/dMMR colorectal cancer. Pembrolizumab first-line: ORR 45%, PFS2 advantage vs chemotherapy. MMR status guides checkpoint inhibitor eligibility. Use the msi-h response rate result to inform your calculation.

Related Calculators

Dukes Stage Survival

Niche Medical Tools

Lynch Syndrome Risk

Niche Medical Tools

FIT False Positive Rate

Niche Medical Tools

Frequently Asked Questions